Datavant to Acquire Aetion, Creating an End-to-End Real-World Evidence Platform

July 13, 2025

Datavant signed an agreement to acquire Aetion, a real-world evidence (RWE) platform used for healthcare and life sciences decision-making. The combined offering is intended to provide end-to-end RWE capabilities spanning data discovery, linkage, privacy, curation, and advanced analysis for regulators and industry stakeholders.

Buyers
Datavant
Targets
Aetion
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.